Adverse drug reactions of Shuanghuanglian injection: A systematic review of public literatures

Journal of Evidence-Based Medicine

Volumn 3, Issue 1, 2010, Pages 18-26

  Wang, Li ^a   Cheng, Lan ^a   Yuan, Qiang ^a   Cui, Xiaohua ^a   Shang, Hongcai ^b   Zhang, Boli ^b   Li, Youping ^a  

^a SICHUAN UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Adverse drug reaction; Shuanghuanglian injection; Systematic review

Indexed keywords

CHINESE DRUG; SULFONAMIDE;

ABDOMINAL PAIN; ALLERGY; ANAPHYLACTIC SHOCK; ASTHMA; BLOOD PRESSURE FLUCTUATION; CHILL; CONVULSION; COUGHING; DEATH; DERMATITIS; DIARRHEA; DIZZINESS; DYSPNEA; EDEMA; FACE EDEMA; FEVER; GASTROINTESTINAL DISEASE; HEADACHE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HUMAN; INJECTION SITE PAIN; LIVER INJURY; NAUSEA AND VOMITING; PARESTHESIA; PHLEBITIS; PRIORITY JOURNAL; PROGNOSIS; RASH; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TACHYCARDIA;

DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL;

EID: 77954605956     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/j.1756-5391.2010.01067.x     Document Type: Review

References (28)

1. Yan M, Wu Y, Guo XX, et al. A Study of the Regulations of the Re-evaluation Skills and Evaluation Modes for Drugs sold on the Market. Chinese Journal of Pharmacoepidemiology 2003; 12(6): 286-289.
2. The SFDA. Adverse Drug Reaction Information Bulletin, 1st issue. [2009-12-5]. Available from: URL: http://www.cdr. gov.cn/gxzy/ ypblfytb/1373.shtml.
3. The SFDA. Adverse Drug Reaction Information Bulletin. The 22th issue.[2009-12-5]. Available from: URL: http://www.cdr. gov.cn/ gxzy/ ypblfytb/8701.shtml.
4. The SFDA. Emergency Notice from the State Food and Drug Administration to Suspend Use and Sales of Shuanghuanglian Injection manufactured by Jiamusi Branch, Wusulijiang Pharmaceutical Company, Heilongjiang.[2009-12-5]. Available from: URL: http://www.sda.gov.cn/ WS01/CL0056 / 35813.html.
5. The SFDA. Notice from the State Food and Drug Administration to Suspend Use and Sales of Shuanghuanglian Injection Labeled by Manufacturer Duoduo Pharmaceutical Co., Ltd.[2009-12-5] Available from: URL: http://www.cdr.gov.cn/ xwdt/gnxw/ 11152.shtml.
6. Wang L, Yang Q, Marshall G, et al. Adverse drug reactions and adverse events of 33 varieties of traditional Chinese medicine injections on the National Essential Drugs List (2004 edition) of China: an overview on published literatures. Journal of Evidence-based Medicine 2010; 3(1).
7. Zhou J, Wu XY, Zhang YM, et al. Analysis of 5165 ADRs cases. Chinese Journal of Drug Application and Monitoring 2004; 1(1): 54-57.
8. Zhao DM, LüZD. Case report of allergic shock caused by Shuanghuanglian. Herald of Medicine 1994; 13(1): 41-44.
9. Zhang GH, Wang DW, Chen HF. An autopsy case of anaphylactic shock cause by Shuanghuanglian Powder. Chinese Journal of Forensic Medicine 1996; 11(4): 203.
10. Lei HG. A case report of dead caused by SHL solution. Chinese Journal of Emergency Medicine 2000; 9(6): 366.
11. Gu LQ. Case report of Shuanghuanglian-induced anaphylactic shock. Journal of Linyi Medical College 2001; 23(3): 221.
12. Li GY, Wang YB. A dead case cause by Shuanghuanglian Powder. Chinese Pharmaceutical Affairs 2001; 15(2): 143-144.
13. Chen ZG. One death case of allergic shock caused by intravenous drip of Shuanghuanglian. Journal of Binzhou Medical University 2002; 25(1): 28.
14. Du YS, Zhou J, Hou HL, et al. Two allergic shock cases caused by intravenous drip of Qingkailing and Shuanghuanglian. Chinese Journal of Forensic Medcine 2002; 17(2): 84.
15. Ju ZL, Zhao XL, Luo DJ. Two severe allergic cases of Shuanghuanglian powder. Shanxi Journal of Traditional Chinese Medicine 2002; 18(6): 41.
16. Wu YK, Fu YJ, Chen YX. One dead case of Shuanghuanglian intravenous injection induced myocardial infarction. Chinese Journal of Rural Medicine and Pharmacy 2002; 9(12): 41.
17. Zheng ZC, Sun XM. One death case of intravenous drip of Shuanghuanglian. Chinese Journal of Rural Medicine and Pharmacy 2002; 9(3): 35.
18. Ai N, Kamilijiang.Three cases of allergic shock caused by Shuanghuanglian Injection.Chinese Journal of Primary Medicine and Pharmacy 2004; 11(7): 817.
19. Yin AQ, Wang JD, An QL. One death case caused by Shuanghuanglian Injection. Chinese Pharmaceutical Affairs 2007; 21(10): 864.
20. Li YG. Clinical comparison of ADRS caused by two types of Shuanghuanglian.Chinese Journal of Modern Drug Application 2009; 3(1): 136-137.
21. Sun BN, Yang JN, Tang GR. Investigation of susceptible population with upper respiratory infection in hospital. Journal of Zhangjiakou Medical College 2000; 17(3): 48-49.
22. Wu JR, Zhang B. Data mining study on adverse reaction induced by Shuanghuanglian injection. Chinese Journal of Pharmacovigilance 2008; 5(3): 139-143.
23. Zhang L,Feng QQ,Yang XH. Analysis and Discussion on Adverse Drug Reaction Events of Traditional Chinese Medicine Injection. Chinese Journal of Pharmacovigilance. 2009; 6(10): 598-602.
24. Cao HS, He PB, Yang LZ. Analysis of 288 allergic shock cases caused by TCM injection. Chinese Journal of Pharmacoepidemiology. 2006; 15(1): 26-27
25. Wu Y, Ren JT, Yan M, et al. Investigation of clinical use of Shuanghuanglian Injection between 2001-2002 in six provinces and cities. Chinese Journal of Pharmacovigilance. 2004; 1(2): 21-23.
26. Wu JR, Zhang B. Epidemiological characteristic of anaphylactic shock cased by Shuanghuanglian Injection. Chinese Traditional Patent Medicine. 2007; 29(5): 638-641.
27. Yang LJ, Song HR, Chu XR, et al. Investigation on the Insoluble Particles of Shuanghuanglian Injection.China and foreign Medical Journal. 2007; 5(10): 12-14.
28. Yang CP. Observation on insoluble particles due to compatibility of Shuanghuanglian or Qingkailing Injection with glucose or sodium injection. Journal of Henan University of Chinese Medicine. 2004; 19(5): 18.